According to Shinpoong Pharm's latest financial reports the company's current EPS (TTM) is -ยฃ0.48. In 2022 the company made an earnings per share (EPS) of -ยฃ0.41 a decrease over its 2021 EPS that were of -ยฃ0.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ0.51 | 23.65% |
2022 | -ยฃ0.41 | 182.43% |
2021 | -ยฃ0.15 | -326.47% |
2020 | ยฃ0.06461 | -8.85% |
2019 | ยฃ0.07088 | 75.6% |
2018 | ยฃ0.04037 | 269.67% |
2017 | ยฃ0.01092 | -103.94% |
2016 | -ยฃ0.28 | -1436.05% |
2015 | ยฃ0.02076 | -71.86% |
2014 | ยฃ0.07377 | -29.56% |
2013 | ยฃ0.10 | -24.55% |
2012 | ยฃ0.14 | -68.07% |
2011 | ยฃ0.43 | 22.65% |
2010 | ยฃ0.35 | 11.53% |
2009 | ยฃ0.32 | 55.55% |
2008 | ยฃ0.20 | 19.44% |
2007 | ยฃ0.17 |